An Adverse Effect Enhanced by Cannabinoids |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Marijuana (MJ) smoking produces inflammation, edema, and cell injury in the tracheobronchial mucosa of
smokers and may be a risk factor for lung cancer. Because oxidative stress may mediate some of these effects, this study was designed to test the hypothesis that cannabinoids in MJ smoke contribute to cellular
oxidative stress. Oxidative stress was evaluated in an endothelial cell line (ECV 304) following exposure
to smoke produced from MJ cigarettes containing either 0, 1.77, or 3.95%
9-tetrahydrocannabinol (
9-THC).
Brief exposure to smoke from 3.95% MJ cigarettes stimulated the formation of reactive oxygen species
(ROS) by 80% over control levels and lowered intracellular glutathione levels by 81%. Smoke-induced ROS generation increased in a dose- and time-dependent manner. In contrast, exposure to smoke from MJ
containing 0%
9-THC produced no increase in ROS despite a 70% decline in glutathione levels. Smoke
from MJ containing 1.77%
9-THC stimulated intermediate levels of ROS. A brief, 30-min exposure to
MJ smoke, regardless of the
9-THC content, also induced necrotic cell death that increased steadily up to
48 h of observation. MJ smoke passed through a Cambridge filter that removed particulate matter was 3.4-fold more active in ROS production compared with unfiltered smoke, suggesting that most of the oxidative
effects are produced by the gaseous phase. Alveolar macrophages obtained from habitual MJ smokers displayed low levels of glutathione compared with macrophages from nonsmokers. We conclude that MJ
smoke containing
9-THC is a potent source of cellular oxidative stress that could contribute significantly
to cell injury and dysfunction in the lungs of smokers.
| |
Introduction |
|---|
|
|
|---|
Marijuana (MJ) is one of the most commonly abused substances in the United States, where 3.3% of young adults
19 to 28 yr of age use MJ on a daily basis and 54% of people between 26 and 34 have used marijuana at least once
(1). Medicinal uses of cannabis date back thousands of
years and both crude smoke and the psychoactive component,
9-tetrahydrocannabinol (
9-THC), have been used
for treating migraine headache, glaucoma, nausea, and anorexia (2). Despite this widespread use, little information
is available regarding toxic effects of MJ smoke. Persistent
efforts to legalize MJ and political movements advocating medicinal uses tend to promote the notion that little or no
hazardous risk is associated with MJ smoking.
The vast majority of research on biologic effects of cannabinoids has addressed the neurologic and psychotropic
activity of these compounds (3). Some publications, however, have documented detrimental effects on the tracheobronchial mucosa, including mucosal edema and inflammation (4), cellular atypia and dysplasia (5), and molecular
dysregulation of genes associated with malignant transformation (6). MJ also appears to alter the function of alveolar macrophages (7), key cells in the lung's immune defenses against infection and malignancy. Moreover, several small
case-series reports have suggested an association between
regular MJ use and upper aerodigestive-tract cancers (8-
13). Approximately 60 different cannabinoids classified as
C-21 terpenophenolic compounds can be found in the
smoke derived from MJ, and the cannabinoid content of
an MJ plant varies considerably depending on the type of
plant and conditions of cultivation. Some reports suggest
that, over the past 10 to 20 yr, the cannabinoid content in
MJ cigarettes may have increased severalfold (14, 15).
There is little information on toxicologic effects of individual constituents found in MJ smoke. In the present studies
we examined the effects of whole MJ cigarette smoke with
and without
9-THC and of the gas phase of the smoke on
the generation of reactive oxygen species (ROS) and on levels of antioxidants in the cultured human endothelial cell
line, ECV 304. Cellular production of ROS and reduced
antioxidant activity were considered to be toxicologic markers of oxidative stress that could lead to cell injury,
DNA damage, and ultimately, malignant transformation.
Human alveolar macrophages collected from the lungs of
habitual MJ smokers were also evaluated for evidence of
in situ exposure to oxidative stress, and were compared
with findings in macrophages from control nonsmokers.
| |
Materials and Methods |
|---|
|
|
|---|
MJ cigarettes containing either 0, 1.77, or 3.95%
9-THC were obtained from the National Institute on Drug
Abuse (NIDA, Rockville, MD) with characteristics as previously described (16). Cigarettes with 1.77 or 3.95%
9-THC were prepared at NIDA by blending MJ leaves of
differing potencies, and cigarettes containing 0%
9-THC
were prepared from MJ leaves that had been extracted
with ethanol to remove cannabinoids. Cigarettes weighed
700 to 900 mg and were weight-matched to within 20 mg
for each experiment. For comparison, tobacco cigarettes
weighing 850 mg were purchased commercially (Marlboro
Red hard-pack filtered cigarettes; Phillip Morris, Richmond, VA). 2,7-Dichlorofluorescein diacetate (DCF-DA) and monochlorobimane (MCB) were from Molecular Probes
(Eugene, OR). Propidium iodide, ascorbic acid, and pyrrolidinedithiocarbamate (PDTC) were from Sigma (St.
Louis, MO). The Promega (Madison, WI) Apoptosis Assay Kit was used for cytotoxicity evaluation.
The endothelial cell line, ECV 304, was obtained from American Type Culture Collection (Rockville, MD). Methods for transfection-mediated overexpression of the human peroxiredoxin (Prx) gene and characterization of antioxidant properties have been described elsewhere (17). The Prx protein confers cellular protection against oxidative stress by consuming hydrogen peroxide (H2O2). Cells were cultured in RPMI 1640 media containing 10% fetal calf serum (FCS) and 1% penicillin/streptomycin/fungizone mix (GIBCO BRL, Grand Island, NY) on poly-L-lysine dishes and multiwell plates. Cells were passaged every 7 d. Prx-transfected cells were cultured alongside control (vector-only)-transfected cells in 24-well plates.
Lung alveolar macrophages were obtained by bronchoalveolar lavage from human volunteers, including both nonsmokers and habitual smokers of MJ only as previously described (5, 7). Macrophages were suspended in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS and 1% penicillin/streptomycin/fungizone. Cells were plated at a density of 5 × 104/well in 96-well plates. Cells were analyzed for endogenous ROS generation and reduced glutathione (GSH) content at 1 and 24 h after plating.
ECV 304 cells transfected with either hygromycin-resistance vector DNA (vec) or a human Prx DNA construct
were treated for 2 h with various agents (ascorbate,
9-THC,
H2O2, or control medium) in 24-well culture plates (2 × 104 cells/well) before loading with 40 µM DCF-DA for 20 min in Krebs-Ringer buffer. After washing twice with
Krebs-Ringer buffer, agents were reapplied to cells in 200 µl Krebs-Ringer buffer and plates were placed in separate
5,000-ml chambers (Billups-Rothenberg, Del Mar, CA)
connected to manually controlled smoking devices (Figure 1). A cigarette holder was attached to a 50-ml sintered
glass syringe using 0.7 cm inner-diameter tygon tubing and
a three-way stopcock connector. After aspiration of smoke
into the syringe, the stopcock valve was turned and smoke
expelled into the vented chamber with brief flushing to ensure thorough distribution of smoke. Each chamber received 10 50-ml boluses, equivalent to smoke from a full
cigarette, and remained exposed to the smoke for 5 min.
Separate chambers exposed to either tobacco or different potencies of MJ smoke were run in parallel and compared
with chambers containing room air as a control. Cellular
oxidative stress was measured fluorometrically by monitoring the oxidation of intracellular 2,7-dichlorofluorescein (DCF) using a Cytofluor 2300 plate reader (PerSeptive Biosystems, Framingham, MA) at excitation (Ex) = 485, emission (Em) = 530 as previously described (18).
Cells were then returned to their respective chambers for
a second exposure to the appropriate smoke for a period
of 15 min. After a second fluorescence measurement, GSH
content, cell viability, and total cell number were measured in a sequential manner as described previously (18).
Smoke contains both gaseous and particulate phases. In
some experiments, the independent effects of the gaseous phase were determined by passing smoke through a high-efficiency Cambridge filter before venting it into chambers
containing the ECV 304 cells.
|
The capacity for MJ smoke to induce intracellular oxidative stress was compared with its ability to directly oxidize DCF in a cell-free environment. In these studies, 24-well plates were filled with 200 µl of Krebs-Ringer buffer containing either DCF-DA-loaded ECV 304 cells as previously described or 5 µM partially de-esterified DCF-DA in the absence of any cells. DCF-DA was partially de-esterified by diluting DCF-DA to 5 µM in Krebs-Ringer buffer for 1 h at room temperature before smoke exposure. Plates were exposed concurrently to the smoke from one MJ cigarette for 20 min and sealed with Mylar tape, and DCF fluorescence was measured at 30-min intervals. Selected wells were treated with various agents (ascorbate, THC, H2O2) immediately before smoke exposure to determine their roles as either pro- or antioxidants.
Long-term viability studies were performed by exposing ECV 304 cells in 96-well plates to MJ smoke with or
without
9-THC for 30 min. Control cells were exposed to
room air for a similar time period. After smoke exposure,
smoke was cleared and cells were confined to chambers
containing 10% CO2 at 37°C for subsequent fluorescent
determination of glutathione levels and viability using
MCB, propidium iodide, and the Cytofluor 2300. Cells were
maintained in serum-containing culture media throughout these studies. Apoptotic and necrotic death was evaluated
quantitatively using the Promega Apoptosis Assay Kit.
Staining was analyzed by fluorescent microscopy and
quantified using the Cytofluor 2300 plate reader.
Data were analyzed in most cases using Student's t test
for paired data. Data from Figure 1 were analyzed by analysis of variance (ANOVA). Levels of ROS were compared between unexposed cells (control), cells exposed to
MJ smoke, and cells exposed to 0%
9-THC smoke by
ANOVA, treating all culture plates as independent measurements. Analyses were performed separately for vec
and Prx cells, and also with both types of cells combined.
Multiple-comparison testing was performed between exposure groups using Tukey's method. Results were considered to be significant at P < 0.05. ANOVA was performed
using SAS software (SAS Institute Inc., Cary, NC).
| |
Results |
|---|
|
|
|---|
Intracellular Effects of Smoke Exposure
In vitro studies in which ECV 304 cells were exposed to
whole unfiltered MJ or tobacco smoke revealed rapid oxidation of intracellular DCF. Although not statistically different, the effect of MJ smoke was generally of greater
magnitude than that of tobacco on a per-cigarette basis.
After 20 min total exposure of vector-transfected cells to
two MJ cigarettes, values for DCF oxidation were 1.8-fold
greater than control cells exposed to room air (P < 0.05)
(Figure 2). In Prx-transfected cells, MJ smoke increased
DCF oxidation 1.6-fold. At the same time, intracellular
GSH levels were decreased to 19% of control values (P < 0.001) regardless of the presence of the Prx gene (Figure
3). MJ cigarette smoke devoid of
9-THC produced no significant increase in DCF oxidation relative to controls
(Figure 2), despite a drop in GSH levels comparable to
that caused by the
9-THC containing MJ smoke (Figure
3). Treatment of cells with ascorbic acid (1 mM) or PDTC
(1 mM) suppressed the MJ-induced DCF oxidation by 100 and 99%, respectively (Figure 4), without appreciably affecting GSH levels (data not shown). Similar results were
obtained using cultures of lung alveolar macrophages obtained from bronchoscopy from nonsmoking subjects (data
not shown). Exposure of ECV 304 cells to synthetic purified
9-THC (0.5 mg/ml) produced no significant DCF oxidation above that of vehicle control (ethanol) (data not
shown).
|
|
|
Extracellular Oxidation by Smoke
The capacity for MJ smoke to produce oxidative stress in
ECV 304 cells (cellular ROS) was compared with its oxidative effects on media alone (cell-free ROS; Figure 5). In
the absence of any smoke exposure, DCF fluorescence
was 30-fold higher in wells containing DCF-loaded cells as
compared with wells containing DCF alone, suggesting
basal generation of ROS by ECV 304 cells. After exposure to smoke from 3.9% MJ cigarettes, there was an increase
in cell-free DCF fluorescence (P < 0.02), but it was only
10% of the value observed for cellular ROS. Both the cellular and cell-free oxidation produced by smoke exposure
were inhibited by ascorbic acid (Asc), but the addition of
9-THC directly to the wells had no effect on either basal
or smoke-induced oxidation. In contrast to the pattern of
ROS that resulted after smoke exposure, the addition of
30 mM H2O2 directly into the wells produced a rapid increase in DCF fluorescence that was 4-fold higher in cell-free wells than in wells containing ECV 304 cells. Similar
results were observed following exposure to tobacco smoke (data not shown).
|
Smoke Dose-Response
Dose-response studies for MJ smoke were performed by varying the amount of smoke delivered to ECV 304 cells in vitro over a fixed interval of time. Either two, six, or 10 injections of 50 ml each were delivered into chambers with 5-s intervals between injections. The chambers were sealed for 10 min starting from exposure to the final bolus. Although the increases in DCF oxidation observed over the first 25 min of exposure were not statistically different between groups, dose- and time-dependent increases in DCF oxidation were significant by 45 min of exposure (Figure 6). After 60 min, the cells exposed to six and 10 50-ml injections displayed 25 and 38% higher levels, respectively, of ROS than did unexposed control cells. Exposure to only two 50-ml injections had no significant effect on ROS generation at any time after exposure.
|
Comparison of smoke from 0, 1.77, and 3.95%
9-THC
MJ cigarettes revealed a dose-dependent relationship between cannabinoid content and ROS generation (Table 1).
However, injection of pure synthetic
9-THC in ethanol
directly into 0%
9-THC cigarettes 24 h before smoking
failed to increase ROS generation significantly (data not
shown).
|
Effects on Viability
The effect of MJ smoke on cell viability was examined by
exposing cells to smoke for 30 min in chambers at room
temperature. Cells were exposed in the presence of complete culture media and viability was monitored at periodic
intervals. MJ smoke caused a time-dependent increase in
cell death that reached 78% at 2 d (Figure 7). Control cells
consistently displayed low (3 to 10%) death throughout
this period. Cells exposed to 0%
9-THC smoke also displayed high levels of death (70%) at 2 d. MJ smoke caused
a rapid and sustained decrease in cellular GSH level of
83% after 10 min exposure and 77% after 6 h, with little
further change up to 48 h (Figure 8). Smoke lacking
9-THC lowered GSH levels by only a slightly lesser degree
(71 and 69%, respectively) at these same times. (Differences were not significant.)
|
|
The majority of dead cells after 2 d exposure to MJ smoke had died by necrosis. While the terminal uridine nucleotide end-terminal labeling apoptosis assay revealed sporadic cells with strongly positive staining, condensed nuclei, and fragmentation into apoptotic bodies, the majority of cells were unstained and slightly swollen. In addition, most cells showed positive staining with propidium iodide, indicating loss of membrane integrity. GSH levels displayed biphasic changes, initially declining after smoke exposure and subsequently tending to increase slightly, a pattern characteristic of many oxidation-mediated effects on the cellular antioxidant.
Filtered Smoke
To evaluate independently the gaseous and particulate
phases of smoke for their ability to generate cellular ROS,
smoke was first passed through high-efficiency Cambridge
filters that remove > 98% of particulate components but
allow passage of gas-phase components. Exposure of cells
to gas-phase MJ smoke resulted in an approximately 2-fold
increase in DCF oxidation relative to whole-smoke exposure (Figure 9). DCF oxidation caused by exposure to filtered smoke from ethanol-extracted MJ (0%
9-THC)
was also elevated 3-fold relative to that from exposure to
unfiltered THC-free smoke. Filtered smoke from THC-containing cigarettes caused approximately 30% higher
DCF oxidation than did filtered smoke from ethanol-
extracted cigarettes. When particulate matter on filters
was extracted with dimethyl sulfoxide (DMSO) and applied to cultured cells, DCF oxidation by whole smoke was attenuated by 50 to 70% (data not shown). DMSO alone
had no effect on either basal or MJ smoke-induced DCF
oxidation.
|
Alveolar Macrophages
Cultured lung alveolar macrophages obtained by bronchoalveolar lavage from habitual MJ smokers revealed GSH levels 31% lower than levels in cells obtained from nonsmokers (P < 0.025) (Table 2). However, incubation of these cells with DCF revealed a lower rate of ROS production of borderline statistical significance (P = 0.05) compared with cells from nonsmokers. Cells from both MJ and tobacco smokers contained high amounts of dense intracellular inclusions.
|
| |
Discussion |
|---|
|
|
|---|
Very little research has been devoted to the cytotoxic effects of direct exposure to MJ smoke. Alterations that
have been found in the tracheobronchial mucosa of habitual MJ smokers include mucosal edema and inflammation
(4), cellular atypia and dysplasia (5), and molecular dysregulation of genes associated with malignant transformation (6). In vitro and whole-animal studies suggest that
9-THC has a direct immunosuppressive effect on a variety of immune cells, including macrophages, natural killer
cells, and T lymphocytes (11, 19). Habitual MJ smoking has also been shown to alter alveolar macrophage morphology (20, 21), phagocytic function (7), fungicidal and
bactericidal activity (7, 22), and oxidative burst superoxide
production (22).
In the present studies we examined the effects of short-term (5 to 30 min) exposure to MJ smoke on generation of ROS, levels of reduced GSH, and cell viability in vitro. Exposure to MJ smoke caused a dramatic increase in ROS over control levels, an increase that was as much as 3-fold higher than the increment resulting from exposure to a similar amount of tobacco smoke. The attenuation of DCF oxidation in cells overexpressing the antioxidant gene, Prx, supports the notion that pro-oxidants such as H2O2 were responsible for some of the MJ-induced effects. Prx is a novel antioxidant cytoplasmic enzyme that appears to eliminate peroxides, one of the several classes of ROS known to be generated intracellularly. In the present study, Prx-overexpressing cells displayed consistently lower DCF oxidation than did vector-only-transfected cells. However, the number of experimental determinations for each exposure group was not sufficiently high to achieve statistical significance.
The MJ-induced ROS appeared to be cannabinoid-
dependent because smoke from cigarettes lacking
9-THC
produced no increase in ROS compared with control cells
exposed to room air only. Although the alcohol extraction
procedure used to deplete MJ leaves of cannabinoids
could have removed other tar components essential for
generating oxidative stress, methanol extraction of Marlboro cigarettes did not alter ROS generation produced by
equivalent volumes of smoke (data not shown). Further, MJ cigarettes containing 1.77%
9-THC stimulated intermediate levels of ROS, suggesting a direct dose-response
relationship. The particulate phase of MJ smoke is qualitatively similar in composition to that of tobacco smoke, with the major exception being that MJ tar contains
9-THC and approximately 60 other cannabinoid compounds
not found in tobacco. Conversely, tobacco tar contains nicotine not found in MJ (7). Because purified
9-THC added
to cells failed to produce significant changes in ROS, GSH,
or cell viability, it is likely that pyrrolysis products produced in the presence of cannabinoids, rather than
9-THC
itself, were responsible for the observed oxidative injuries. The strong effects of MJ smoke on GSH levels and cell viability were not appreciably influenced by
9-THC content. This disparity suggests that DCF oxidation and GSH depletion are affected to some extent by different components in MJ smoke.
After intracellular loading and de-esterification, dihydro-DCF can be oxidized to its fluorescent derivative, DCF, by a variety of agents including hydrogen peroxide, hydroxyl radical, and peroxynitrite (23, 24). Evidence indicates that the fluorescent compound is not permanently retained within cells as originally proposed (25), but is gradually released into the surrounding medium. This slow release of dihydro-DCF could diminish the signal caused by oxidants of intracellular origin and increase signal from extracellular oxidants adsorbed directly from smoke. However, our studies comparing cellular and noncellular oxidation of DCF by MJ smoke revealed that DCF in buffer solution is poorly oxidized by direct smoke exposure, in contrast to results obtained with cellular DCF measurements (Figure 5). These results suggest that most of the DCF fluorescence results from smoke exposure generated by cellular mechanisms. Smoke-induced disruption of mitochondrial or endoplasmic reticular electron transport is among the possible mechanisms for such ROS generation.
Our studies revealed that, compared with smoke generated from MJ cigarettes containing 0%
9-THC, unmodified MJ smoke deposited 50% higher amounts of nitrates (NO/NO2
/NO3
) into culture wells (data not shown). Nitrates can generate peroxynitrite in the presence of superoxide anion. This effect may partially account for the difference in ROS produced from MJ with or without
9-THC.
However, smoke from a tobacco cigarette of equivalent
weight contained nearly twice as much nitrate as smoke
from 3.9%
9-THC MJ cigarettes, yet produced somewhat
lower ROS. Thus, smoke nitrate levels did not correlate
directly with ROS generation.
Loss of cellular GSH can occur by two major pathways (26). Free radical-mediated oxidative activity results in generation and/or efflux of oxidized glutathione, which we did not measure in this study. Alternatively, nucleophiles, including aldehydes known to be prevalent in cigarette smoke (e.g., formaldehyde), form covalent conjugates with GSH. These reactions, catalyzed by glutathione-S-transferase (GST) enzymes, result in lower MCB-detectable GSH levels. These reactions do not necessarily reflect oxidative stress per se, but would partially impair cellular defenses and inhibit the removal of ROS. MCB has been used extensively to estimate intracellular levels of reduced GSH (27). Although fluorescence can also be generated by protein-MCB conjugate formation (31), the rate of this reaction at low (10 to 100 µM) concentrations of MCB is lower than that for the complex with GSH. Thus, limiting the reaction time to 20 min allows for a more accurate estimation of GSH. Recent studies suggest that reactivity of MCB with GSH is low in human peripheral blood monocytes compared with reactivity with other low molecular-weight compounds (32). This low reactivity is apparently due to the low affinity of some forms of GSTs for MCB. In the present study, the human alveolar macrophages displayed 20 to 60% lower levels of MCB fluorescence than did the ECV 304 cell line. However, in both cell types, MCB fluorescence was inhibited 80 to 90% by 10 min pretreatment with 2 mM diethylmaleate, which rapidly removes cytoplasmic GSH (33).
Cannabinoids, including THC, contribute substantially
to the particulate mass of MJ smoke comprising 20 to 30%
of the total tar weight for cigarettes containing 3.9%
9-THC
(13). To determine whether the increased particulate material in MJ smoke was responsible for the enhanced DCF
oxidation, MJ cigarette smoke was passed through Cambridge filters before exposure to cells. Such filters trap > 98% of particulate material but permit passage of all gaseous elements. This procedure not only failed to attenuate
DCF oxidation, but also greatly stimulated oxidation in
both unmodified MJ and THC-deficient smoke. This stimulation was consistent with reports of strong oxidizing activity of the gaseous phase of tobacco cigarette smoke after removal of particulates by filtration. For example, in
studies on the role of tobacco smoke in atherosclerosis,
oxidation of low-density lipoprotein (LDL) has been observed with filtered smoke but not whole smoke (34). Filter-trapped particulates can inhibit LDL oxidation induced by cupric chloride or azo-bis (2-amidinopropane), and it has been suggested that antioxidants, such as
polyphenolic compounds found in smoke particulate fractions, may be responsible for inhibition of LDL oxidation
(35, 36). In the present studies, the concept that particulate
components of MJ smoke had antioxidant properties was
further supported by the finding that DMSO extracts of a
Cambridge filter pad absorbed with MJ smoke particulates suppressed ROS generation. Thus, the level of
smoke-induced cellular ROS appears to be a function of
the relative amounts of gaseous-phase pro-oxidants and
particle-phase antioxidants.
The cannabinoids present in the particle phase of MJ
smoke, including
9-THC and cannabinol, have been reported to have antioxidant properties as measured by cyclic voltametry and by their ability to prevent H2O2-mediated oxidation of a fluorescent probe (37). This is consistent
with their known structure, which includes hydroxyl groups
and aliphatic rings. However, the addition of
9-THC to
our assays before smoke exposure did not provide any
measurable antioxidant protection, suggesting that this effect is relatively weak compared with the pro-oxidant activity induced by smoke.
Preliminary studies with cultured lung alveolar macrophages from human MJ smokers demonstrated lower levels of GSH in these cells than in alveolar macrophages from nonsmokers. These results suggest that habitual exposure to MJ smoke causes a sustained decrease in GSH-dependent oxidative defenses. Such a decrease could be due to inhibition of GSH synthetic or recycling enzymes concomitant with depletion of cytoplasmic GSH. Inhibition of GST could also contribute to diminished MCB fluorescence because this enzyme accelerates MCB-GSH conjugation. The observed decrease in rate of ROS production in cells from MJ smokers relative to nonsmokers is, seemingly, paradoxical. One explanation consistent with the cytotoxic effects of MJ smoke is that chronic in vivo exposure of cells to this smoke produced general metabolic impairments diminishing either mitochondrial electron transport or oxidative burst capacity.
The generation of ROS has several undesirable consequences, including the impairment of cellular energetic (38) and defense (39) systems and the promotion of malignant transformation (40). Cell death induced by MJ smoke is largely necrotic. These deleterious effects of MJ smoke could have serious implications for tissues in direct contact with cannabinoid-containing smoke, including lung macrophages and surface epithelial cells in the upper aerodigestive tract and the tracheobronchial mucosa. Such effects need to be taken into consideration when evaluating risk-benefit factors associated with MJ consumption.
| |
Footnotes |
|---|
Address correspondence to: T. A. Sarafian, Div. of Pulmonary and Critical Care Medicine, Dept. of Medicine, UCLA School of Medicine, Los Angeles, CA 90095.
(Received in original form May 15, 1998 and in revised form December 23, 1998).
Abbreviations: analysis of variance, ANOVA; ascorbic acid, Asc; 2,7-dichlorofluorescein, DCF; DCF diacetate, DCF-DA; dimethyl sulfoxide, DMSO; emission, Em; excitation, Ex; fetal calf serum, FCS; reduced glutathione, GSH; glutathione-S-transferase, GST; hydrogen peroxide, H2O2; low-density lipoprotein, LDL; monochlorobimane, MCB; marijuana, MJ; pyrrolidinedithiocarbamate, PDTC; peroxiredoxin, Prx; reactive oxygen species, ROS; standard error of the mean, SEM; tetrahydrocannabinol, THC.Acknowledgments: The authors are grateful to Bianca Grigorian, Priya Pilutla, Angela Chang, Nancy Pashayan, Amy Ling, Pramod Patel, and Ruth Chang for technical assistance; and they thank Donna Crandall and Carol Gray for illustrations, Fernando Casimiro for word processing, and Mike Simmons for statistical analyses. This work was supported by grant #DA 03018 from the National Institute on Drug Abuse.
| |
References |
|---|
|
|
|---|
1. Johnston, L. D., P. M. O'Malley, and J. G. Bachman. 1997. National survey results on drug use from the Monitoring the Future Study, 1975-1995, Vol II. College students and young adults. USDHHS, NIH Publication No. 98-4140, Washington, DC. 35-74.
2. Grinspoon, L., and J. B. Bakalar, 1997. Marijuana: The Forbidden Medicine, Revised and Expanded Edition, Yale University Press, New Haven, CT.
3. Adams, I. B., and B. R. Martin. 1996. Cannabis: pharmacology and toxicology in animals and humans. Addiction 91: 1585-1614 [Medline].
4.
Roth, M. D.,
A. Arora,
S. H. Barsky,
E. C. Kleerup,
M. Simmons, and
D. P. Tashkin.
1998.
Visual and pathologic evidence of injury to the airways of
young marijuana smokers.
Am. J. Respir. Crit. Care Med.
157:
928-937
5.
Fligiel, S. E.,
M. D. Roth,
E. C. Kleerup,
S. H. Barsky,
M. S. Simmons, and
D. P. Tashkin.
1997.
Tracheobronchial histopathology in habitual smokers
of cocaine, marijuana, and/or tobacco.
Chest
112:
319-326
6.
Barsky, S. H.,
M. D Roth,
E. C. Kleerup,
M. Simmons, and
D. P. Tashkin.
1998.
Histopathologic and molecular alterations in bronchial epithelium in
habitual smokers of marijuana, cocaine, and/or tobacco.
J. Natl. Cancer Inst.
90:
1198-1205
7.
Baldwin, G. C.,
D. P. Tashkin,
D. M. Buckley,
A. N. Park,
S. M. Dubinett, and
M. D. Roth.
1997.
, Habitual smoking of marijuana and cocaine impairs
alveolar macrohage function and cytokine production.
Am. J. Respir. Crit.
Care Med.
156:
1606-1613
8. Taylor, F. M.. 1988. Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med. J 81: 1213-1216 [Medline].
9. Caplan, G. A., and B. A. Brigham. 1990. Marijuana smoking and carcinoma of the tongue: is there an association? Cancer 66: 1005-1006 [Medline].
10. Donald, P. J.. 1991. Advanced malignancy in the young marijuana smoker. Adv. Exp. Med. Biol. 288: 33-46 [Medline].
11. Klein, T. S., Y. Kawakami, C. Newton, and H. Friedman. 1991. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Env. Health 32: 465-477 [Medline].
12.
Kusher, D. I.,
L. O. Dawson,
A. C. Taylor, and
J. Y. Djeu.
1994.
Effect of the
psychoactive metabolite of marijuana,
9-tetrahydrocannabinol (THC), on
the synthesis of tumor necrosis factor by human large granular lymphocytes.
Cell. Immunol.
154:
99-108
[Medline].
13. Hoffman, D., D. K. Brunneman, G. B. Gori, and E. L. Wynder. 1975. On the carcinogenicity of marijuana smoke. Rec. Adv. Phytochem. 9: 63-81 .
14. ElSohly, M. A., and S. A. Ross. 1994. Quarterly Report, NIDA Potency Monitoring Project, Report No. 50. National Institute on Drug Abuse, Rockville, MD.
15. Zimmer, L., and J. P. Morgan. 1997. Marijuana Myths, Marijuana Facts. Lindesmith Center, New York. 135-141.
16. Matthias, P., D. P. Tashkin, J. A. Marques, Magallanes, J. N. Wilkins, and M. S. Simmons. 1997. Effects of varying marijuana potency on deposition of tar and delta-9-THC in the lung during smoking. Pharmacol. Biochem. Behav. 58: 1145-1150 [Medline].
17. Sarafian, T. A., N. Rajper, B. Grigorian, A. Kim, and H. Shau. 1997. Cellular antioxidant properties of human natural killer enhancing factor B. Free Rad. Res. 26: 281-289 [Medline].
18. Sarafian, T. A., L. Vartavarian, D. J. Kane, D. E. Bredesen, and M. A. Verity. 1994. bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line. Toxicol. Lett. 74: 149-155 [Medline].
19.
Burnette-Curley, D., and
G. A. Cabral.
1995.
Differential inhibition of
RAW264.7 macrophage tumoricidal activity by
9-tetrahydrocannabinol.
Proc. Soc. Exp. Biol. Med.
210:
64-76
[Abstract].
20. Davies, P., G. C. Sornberger, and G. L. Huber. 1979. Effects of experimental marijuana and tobacco smoke inhalation on alveolar macrophages. Lab. Invest. 41: 220-223 [Medline].
21. Beals, T. F., S. E. G. Fligiel, S. Stuth, and D. P. Tashkin. 1989. Morphological alterations of alveolar macrophages from marijuana smokers. Am. Rev. Respir. Dis. 139: A336 . (Abstr.) .
22. Sherman, M. P., L. A. Campbell, H. Gong Jr., M. D. Roth, and D. P. Tashkin. 1991. Respiratory burst and microbicidal characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco and nonsmokers. Am. Rev. Respir. Dis. 144: 1351-1356 [Medline].
23. Lebel, C. P., H. Ischiropoulos, and S. C. Bondy. 1992. Evaluation of the probe 2',7'-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5: 227-231 [Medline].
24. Possel, H., H. Noack, W. Augustin, G. Keilhoff, and G. Wolf. 1997. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett. 416: 175-178 [Medline].
25. Bass, D. A., J. W. Parce, L. R. Dechatelet, P. Szejda, M. C. Seeds, and M. Thomas. 1983. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130: 1910-1917 [Abstract].
26. Bellomo, G., H. Thor, and S. Orrenius. 1990. Modulation of cellular glutathione and protein thiol status during quinone metabolism. Methods Enzymol. 186: 627-635 [Medline].
27. Rice, G. C., E. A. Bump, D. C. Shrieve, W. Lee, and M. Kovacs. 1986. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res. 46: 6105-6110 [Medline].
28.
Shrieve, D. C.,
E. A. Bump, and
G. C. Rice.
1988.
Heterogeneity of cellular
glutathione among cells derived from a murine fibrosarcoma or a human
renal cell carcinoma detected by flow cytometric analysis.
J. Biol. Chem.
263:
14107-14114
29. Kavanagh, T. J., A. Grossman, J. C. Jinnerman, S. B. Kanner, C. C. White, D. L. Eaton, J. A. Ledbetter, and P. S. Rabinovitch. 1993. The effect of 1-chloro-2,4-dinitrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes. Toxicol. Appl. Pharmacol. 119: 91-99 [Medline].
30. Reichelt, W., J. Stabel-Burow, T. Pannicke, H. Weichert, and U. Heinemann. 1997. The glutathione level of retinal Muller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience 77: 1213-1224 [Medline].
31.
Cook, J. A.,
H. I. Pass,
S. N. Iype,
N. Friedman,
W. DeGraff,
A. Russo, and
J. B. Mitchell.
1991.
Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue.
Cancer Res.
51:
4287-4294
32. van der Ven, A. J. A. M., P. Mier, W. H. M. Peters, H. Dolstra, P. E. J. van Erp, P. P. Koopmans, and J. W. M. van der Meer. 1994. Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells. Anal. Biochem. 217: 41-47 [Medline].
33. Ku, R. H., and R. E. Billings. 1986. The role of mitochondrial glutathione and cellular protein sulfhydryls in formaldehyde toxicity in glutathione- depleted rat hepatocytes. Arch. Biochem. 247: 183-189 .
34. Frei, B., T. M. Forte, B. N. Ames, and C. E. Cross. 1991. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem. J. 277: 133-138 .
35. Chen, C., and G. Loo. 1995. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis 112: 177-185 [Medline].
36. Church, D. F., and W. A. Prior. 1985. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64: 111-126 [Medline].
37.
Hampson, A. J.,
M. Grimaldi,
J. Axelrod, and
D. Wink.
1998.
Cannabidiol
and (-)
9-tetrahydrocannabinol are neuroprotective antioxidants.
Proc.
Natl. Acad. Sci. USA
95:
8268-8273
38. Wallace, K. B., J. T. Eelss, V. M. C. Madeira, G. Cortopassi, and D. P. Jones. 1997. Mitochondria-mediated cell injury. Fundam. Appl. Toxicol. 38: 23-37 [Medline].
39.
Repine, J. E.,
A. Bast,
I. Lankhorst, and
The Oxidative Stress Study Group.
1997.
Oxidative stress in chronic obstructive pulmonary disease.
Am. J. Respir. Crit. Care Med.
156:
341-357
40. Bankson, D. D., M. Kestin, and N. Rifai. 1993. Role of free radicals in cancer and atherosclerosis. Clin. Lab. Med. 13: 463-480 [Medline].
This article has been cited by other articles:
![]() |
S. Aldington, M. Williams, M. Nowitz, M. Weatherall, A. Pritchard, A. McNaughton, G. Robinson, and R. Beasley Effects of cannabis on pulmonary structure, function and symptoms Thorax, December 1, 2007; 62(12): 1058 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehra, B. A. Moore, K. Crothers, J. Tetrault, and D. A. Fiellin The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med, July 10, 2006; 166(13): 1359 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kraft and H. G. Kress Indirect CB2 Receptor and Mediator-Dependent Stimulation of Human Whole-Blood Neutrophils by Exogenous and Endogenous Cannabinoids J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Mao, I-H. Tsu, S. M. Dubinett, B. Adams, T. Sarafian, F. Baratelli, M. D. Roth, and K. J. Serio Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide Clin. Cancer Res., October 15, 2004; 10(20): 6872 - 6878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Sarafian, S. Kouyoumjian, F. Khoshaghideh, D. P. Tashkin, and M. D. Roth Delta 9-Tetrahydrocannabinol disrupts mitochondrial function and cell energetics Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L298 - L306. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |